BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34286631)

  • 21. Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer.
    Oliveira ALCSL; Zerillo L; Cruz LJ; Schomann T; Chan AB; de Carvalho TG; Souza SVP; Araújo AA; de Geus-Oei LF; de Araújo Júnior RF
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111678. PubMed ID: 33545840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabrication of levofloxacin polyethylene glycol decorated nanoliposomes for enhanced management of acute otitis media: Statistical optimization, trans-tympanic permeation and in vivo evaluation.
    Abdelbary AA; Abd-Elsalam WH; Al-Mahallawi AM
    Int J Pharm; 2019 Mar; 559():201-209. PubMed ID: 30684597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-Tumor Efficacy of Pyrvinium Pamoate Nanoliposomes in an Experimental Model of Melanoma.
    Hatamipour M; Jaafari MR; Zangui M; Shakour N; Sahebkar A
    Anticancer Agents Med Chem; 2021; 21(17):2379-2384. PubMed ID: 33596812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation, Characterization, and Anticancer Effects of Capsaicin-Loaded Nanoliposomes.
    Al-Samydai A; Alshaer W; Al-Dujaili EAS; Azzam H; Aburjai T
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting of high mobility group A2 by small interfering RNA-loaded nanoliposome-induced apoptosis and migration inhibition in gastrointestinal cancer cells.
    Mohammadi A; Mansoori B; Savadi P; Khaze V; Minouei M; McMillan NAJ; Hallaj-Nezhadi S; Baradaran B
    J Cell Biochem; 2019 Jun; 120(6):9203-9212. PubMed ID: 30507008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib-Loaded Long-Circulating Nanoliposomes for Liver Cancer Therapy.
    Ye H; Zhou L; Jin H; Chen Y; Cheng D; Jiang Y
    Biomed Res Int; 2020; 2020():1351046. PubMed ID: 32461962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large scale preparation of midkine antisense oligonucleotides nanoliposomes by a cross-flow injection technique combined with ultrafiltration and high-pressure extrusion procedures.
    Zhong J; Yao X; Li DL; Li LQ; Zhou LF; Huang HL; Min LS; Li J; Fu FF; Dai LC
    Int J Pharm; 2013 Jan; 441(1-2):712-20. PubMed ID: 23142083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic antitumor effect of anti-PD-L1 combined with oxaliplatin on a mouse tumor model.
    Golchin S; Alimohammadi R; Rostami Nejad M; Jalali SA
    J Cell Physiol; 2019 Nov; 234(11):19866-19874. PubMed ID: 30941773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
    Sen K; Banerjee S; Mandal M
    Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superparamagnetic chitosan nanocomplexes for colorectal tumor-targeted delivery of irinotecan.
    Wu D; Zhu L; Li Y; Wang H; Xu S; Zhang X; Wu R; Yang G
    Int J Pharm; 2020 Jun; 584():119394. PubMed ID: 32407940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Encapsulation of gemcitabine in RGD-modified nanoliposomes improves breast cancer inhibitory activity.
    Cai W; Geng C; Jiang L; Sun J; Chen B; Zhou Y; Yang B; Lu H
    Pharm Dev Technol; 2020 Jun; 25(5):640-648. PubMed ID: 32028816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung-targeting drug delivery system of baicalin-loaded nanoliposomes: development, biodistribution in rabbits, and pharmacodynamics in nude mice bearing orthotopic human lung cancer.
    Wei Y; Liang J; Zheng X; Pi C; Liu H; Yang H; Zou Y; Ye Y; Zhao L
    Int J Nanomedicine; 2017; 12():251-261. PubMed ID: 28096670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic Okra gum coated nanoliposomes as a pH-sensitive carrier for co-delivery of hesperetin and oxaliplatin in colorectal cancers.
    Hodaei M; Varshosaz J
    Pharm Dev Technol; 2022 Sep; 27(7):773-784. PubMed ID: 36040153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of antitumor immunity contributes to the enhanced therapeutic efficacy of liposomal oxaliplatin in mouse model.
    Shimizu T; Abu Lila AS; Nishio M; Doi Y; Ando H; Ukawa M; Ishima Y; Ishida T
    Cancer Sci; 2017 Sep; 108(9):1864-1869. PubMed ID: 28643902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells.
    Li L; Xiang D; Shigdar S; Yang W; Li Q; Lin J; Liu K; Duan W
    Int J Nanomedicine; 2014; 9():1083-96. PubMed ID: 24591829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?
    Abu Lila AS; Okada T; Doi Y; Ichihara M; Ishida T; Kiwada H
    Int J Pharm; 2012 Apr; 426(1-2):263-270. PubMed ID: 22310465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.
    Limagne E; Thibaudin M; Nuttin L; Spill A; Derangère V; Fumet JD; Amellal N; Peranzoni E; Cattan V; Ghiringhelli F
    Cancer Immunol Res; 2019 Dec; 7(12):1958-1969. PubMed ID: 31611243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone.
    Sun G; Sun K; Sun J
    Drug Deliv; 2021 Dec; 28(1):1132-1140. PubMed ID: 34121558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice.
    Zhao Y; Wang H; Yang Y; Jia W; Su T; Che Y; Feng Y; Yuan X; Wang X
    Int J Nanomedicine; 2020; 15():9571-9586. PubMed ID: 33293808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.